Schneider National, Inc. (SNDR)
NYSE: SNDR · Real-Time Price · USD
23.98
-0.18 (-0.75%)
Aug 8, 2025, 4:00 PM - Market closed
Marinus Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
| 5,477 | 5,291 | 5,499 | 6,604 | 5,609 | 4,553 | Upgrade | |
Revenue Growth (YoY) | 2.20% | -3.79% | -16.74% | 17.75% | 23.19% | -4.09% | Upgrade |
Cost of Revenue | 4,555 | 4,436 | 4,557 | 5,334 | 4,551 | 3,777 | Upgrade |
Gross Profit | 922.3 | 854.8 | 941.9 | 1,271 | 1,058 | 775.8 | Upgrade |
Selling, General & Admin | 303.2 | 273.9 | 262.1 | 262.8 | 215.3 | 192.9 | Upgrade |
Operating Expenses | 737.5 | 687.6 | 644.6 | 612.8 | 511.5 | 483.4 | Upgrade |
Operating Income | 184.8 | 167.2 | 297.3 | 657.7 | 546.2 | 292.4 | Upgrade |
Interest Expense | -24.7 | -16.6 | -14.2 | -9.6 | -12.5 | -13.6 | Upgrade |
Interest & Investment Income | 5.7 | 4.3 | 7 | 2.9 | 2.1 | 3.3 | Upgrade |
Other Non Operating Income (Expenses) | -2.9 | -3 | -2.8 | -3.4 | -2.9 | -2.3 | Upgrade |
EBT Excluding Unusual Items | 162.9 | 151.9 | 287.3 | 647.6 | 532.9 | 279.8 | Upgrade |
Merger & Restructuring Charges | -2.2 | -2 | -0.9 | -0.3 | -1.9 | -1 | Upgrade |
Impairment of Goodwill | - | - | - | - | -10.6 | - | Upgrade |
Gain (Loss) on Sale of Investments | 2 | 2.3 | 19.7 | 13.7 | 21.6 | 8.8 | Upgrade |
Asset Writedown | - | - | - | - | - | -4.7 | Upgrade |
Legal Settlements | - | - | - | -57 | - | - | Upgrade |
Pretax Income | 162.7 | 152.2 | 306.1 | 604 | 542 | 282.9 | Upgrade |
Income Tax Expense | 37.4 | 35.2 | 67.6 | 146.2 | 136.6 | 71.2 | Upgrade |
Net Income | 125.3 | 117 | 238.5 | 457.8 | 405.4 | 211.7 | Upgrade |
Net Income to Common | 125.3 | 117 | 238.5 | 457.8 | 405.4 | 211.7 | Upgrade |
Net Income Growth | 7.28% | -50.94% | -47.90% | 12.93% | 91.50% | 44.01% | Upgrade |
Shares Outstanding (Basic) | 175 | 176 | 177 | 178 | 178 | 177 | Upgrade |
Shares Outstanding (Diluted) | 176 | 176 | 178 | 179 | 178 | 178 | Upgrade |
Shares Change (YoY) | -0.54% | -1.18% | -0.34% | 0.39% | 0.28% | 0.17% | Upgrade |
EPS (Basic) | 0.71 | 0.67 | 1.35 | 2.57 | 2.28 | 1.19 | Upgrade |
EPS (Diluted) | 0.70 | 0.66 | 1.34 | 2.56 | 2.28 | 1.19 | Upgrade |
EPS Growth | 5.54% | -50.75% | -47.66% | 12.28% | 91.60% | 43.37% | Upgrade |
Free Cash Flow | 164.5 | 146.8 | -127.6 | 162.8 | 25.5 | 199.2 | Upgrade |
Free Cash Flow Per Share | 0.94 | 0.83 | -0.72 | 0.91 | 0.14 | 1.12 | Upgrade |
Dividend Per Share | 0.380 | 0.380 | 0.360 | 0.320 | 0.320 | 0.260 | Upgrade |
Dividend Growth | 2.70% | 5.56% | 12.50% | - | 23.08% | 8.33% | Upgrade |
Gross Margin | 16.84% | 16.16% | 17.13% | 19.24% | 18.86% | 17.04% | Upgrade |
Operating Margin | 3.37% | 3.16% | 5.41% | 9.96% | 9.74% | 6.42% | Upgrade |
Profit Margin | 2.29% | 2.21% | 4.34% | 6.93% | 7.23% | 4.65% | Upgrade |
Free Cash Flow Margin | 3.00% | 2.77% | -2.32% | 2.46% | 0.46% | 4.38% | Upgrade |
EBITDA | 586.6 | 548.4 | 649.9 | 981.9 | 821.2 | 567.5 | Upgrade |
EBITDA Margin | 10.71% | 10.37% | 11.82% | 14.87% | 14.64% | 12.46% | Upgrade |
D&A For EBITDA | 401.8 | 381.2 | 352.6 | 324.2 | 275 | 275.1 | Upgrade |
EBIT | 184.8 | 167.2 | 297.3 | 657.7 | 546.2 | 292.4 | Upgrade |
EBIT Margin | 3.37% | 3.16% | 5.41% | 9.96% | 9.74% | 6.42% | Upgrade |
Effective Tax Rate | 22.99% | 23.13% | 22.08% | 24.20% | 25.20% | 25.17% | Upgrade |
Updated Jul 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.